The Vitiligo & Pigmentation Institute of Southern California has an ongoing Clinical Trials program that focuses on a variety of skin and hair disorders.
As a recognized leader in dermatological studies, VPI houses a Clinical Trials department with an unparalleled staff. Keeping up-to-date with ever-changing protocols, new developments and adhering to good clinical practice procedures are only a few reasons why pharmaceutical companies request VPI to partner in new studies. Past studies include Phase III studies for FDA approval of BOTOX®, Phase III studies for FDA approval of Juvéderm®, Tazorac and BLAH studies.
(323) 467-4389 Ext: 210